Budros Ruhlin & Roe Inc. acquired a new stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) during the first quarter, according to its most recent 13F filing with the SEC. The fund acquired 9,638 shares of the pharmacy operator’s stock, valued at approximately $610,000.
A number of other institutional investors have also recently made changes to their positions in WBA. Horan Capital Advisors LLC. bought a new stake in shares of Walgreens Boots Alliance during the first quarter valued at about $25,000. Massey Quick Simon & CO. LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at about $27,000. Murphy Pohlad Asset Management LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at about $29,000. Cornerstone Advisors Inc. increased its position in shares of Walgreens Boots Alliance by 102.4% during the third quarter. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 214 shares during the period. Finally, PRW Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at about $34,000. Institutional investors and hedge funds own 64.77% of the company’s stock.
WBA traded up $0.18 during midday trading on Wednesday, hitting $52.94. The stock had a trading volume of 2,928,450 shares, compared to its average volume of 6,516,903. The firm has a market cap of $48.40 billion, a P/E ratio of 8.79, a P/E/G ratio of 1.06 and a beta of 0.77. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.78 and a quick ratio of 0.38. Walgreens Boots Alliance Inc has a 1 year low of $51.79 and a 1 year high of $86.31.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.70 by ($0.06). The firm had revenue of $34.53 billion during the quarter, compared to analysts’ expectations of $34.57 billion. Walgreens Boots Alliance had a return on equity of 22.00% and a net margin of 3.77%. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.73 EPS. On average, equities analysts anticipate that Walgreens Boots Alliance Inc will post 5.99 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Monday, May 20th will be paid a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.32%. The ex-dividend date is Friday, May 17th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 29.24%.
WBA has been the subject of several recent analyst reports. Loop Capital set a $82.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Wednesday, January 23rd. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Thursday, February 14th. Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, February 26th. Robert W. Baird cut their price objective on Walgreens Boots Alliance from $70.00 to $67.00 and set a “neutral” rating for the company in a report on Friday, March 1st. Finally, ValuEngine lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Friday, March 1st. Five analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $68.00.
In related news, COO Ornella Barra acquired 18,000 shares of the company’s stock in a transaction dated Wednesday, April 3rd. The stock was purchased at an average price of $54.56 per share, with a total value of $982,080.00. Following the completion of the purchase, the chief operating officer now owns 26,425 shares in the company, valued at approximately $1,441,748. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $53.05, for a total value of $1,061,000.00. Following the transaction, the chief accounting officer now owns 435,811 shares of the company’s stock, valued at approximately $23,119,773.55. The disclosure for this sale can be found here. Corporate insiders own 15.73% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece of content was first reported by Sundance Herald and is the sole property of of Sundance Herald. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark law. The correct version of this piece of content can be read at https://sundanceherald.com/2019/05/22/9638-shares-in-walgreens-boots-alliance-inc-wba-acquired-by-budros-ruhlin-roe-inc.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: Earnings Per Share (EPS)
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.